Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Jan 18, 2022

SELL
$4.02 - $16.84 $29,747 - $124,616
-7,400 Reduced 16.63%
37,100 $389,000
Q3 2021

Oct 26, 2021

BUY
$9.26 - $31.31 $412,070 - $1.39 Million
44,500 New
44,500 $225,000

Others Institutions Holding BYSI

About BeyondSpring Inc.


  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $66.6M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.